How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A research team at POSTECH led by Professor Wook-Shin Han of the Department of Computer Science and Engineering and the ...

Quantum materials are a class of exotic materials with special properties that are governed by quantum mechanics rather than ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Then run individual file to see result on console. You should use node filename in console to see results.

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Welcome everybody to Recursion's Earnings Call. I'm Chris Gibson, Co-Founder and CEO, and I'm excited to take you through Recursions 2024, 2025 and the time ahead. So with that we'll jump into the ...

Recursion Pharmaceuticals. has been granted a patent for a method to identify target proteins using a test ligand. The process involves docking simulations, molecular data extraction, and binding site ...

Recursion Pharmaceuticals has agreed to acquire the Oxford, U.K.-based artificial intelligence (AI) drug pioneer Exscientia, the companies said today, in a deal that consolidates two leaders in ...

Recursion Pharmaceuticals Co-Founder and CEO Chris Gibson joins 'Mad Money' host Jim Cramer to talk integrating machine learnings into drug development and partnering with Nvidia. Got a confidential ...

Abstract: In this paper, a novel recursive data mining method based on the simple but powerful model of cognition called a conceptor is introduced and applied to computer security. The method ...